Survivors ( n = 13) | Non-survivors ( n = 9) | P value | |
---|---|---|---|
Steroid therapy | 7 (54%) | 2 (22%) | 0.15 |
IABP use | 13 (100%) | 8 (89%) | 0.41 |
CHDF use | 2 (15%) | 3 (33%) | 0.32 |
Total operating time of ECMO, h | 181 ± 22 | 177 ± 31 | 0.15 |
Complications associated with ECMO | |||
Total | 3 (23%) | 8 (89%) | 0.004 |
Leg ischemia | 0 (0%) | 2 (22%) | 0.16 |
Stroke | 0 (0%) | 2 (22%) | 0.16 |
Bleeding | 2 (15%) | 6 (67%) | 0.02 |
Multiple organ failure | 2 (15%) | 6 (67%) | 0.02 |